News Focus
News Focus
icon url

learningcurve2020

07/06/25 12:40 PM

#774396 RE: exwannabe #774394

It’s as wrong on everything as it was on claiming NWBO owns Advent. But it doesn’t care since the bad information was disseminated.
icon url

dennisdave

07/06/25 1:10 PM

#774398 RE: exwannabe #774394

The idea that the MAA is being held up for EDEN is, and always has been, total quackery.


Agreed. What it is being held up is the decision on the MAA until the ECA/RWD guideline is published
icon url

Investor082

07/07/25 12:02 AM

#774494 RE: exwannabe #774394

“The idea that the MAA is being held up for EDEN is, and always has been, total quackery.”

— the likes of Guru Gary, Doc Logic, and other minions of LP & LG, who have been broadcasting this are a bunch of liars just like LP and LG. Regulatory agencies will never hold up an approval due to volume, particularly when it’s a novel immunotherapy vaccine. KITE could only produce doses for 100 patients in the first year post FDA approval. Many such examples.

However, what it indicates is that be prepared for a long delay on UK approval. That’s what LP & LG are coaching the minions to position the shareholder expectations in terms of UK approval. Since even Doc logic does not expect Flaskworks to be commercially approved for another year. Personally, I don’t think Flasworks commercial approval will happen in 2026. In fact, we’d be lucky to have it in 2027 given NWBO’s pace.